BR0114912A - Kahalalide f - Google Patents

Kahalalide f

Info

Publication number
BR0114912A
BR0114912A BR0114912-1A BR0114912A BR0114912A BR 0114912 A BR0114912 A BR 0114912A BR 0114912 A BR0114912 A BR 0114912A BR 0114912 A BR0114912 A BR 0114912A
Authority
BR
Brazil
Prior art keywords
kahalalide
relates
new formulations
formulations
new
Prior art date
Application number
BR0114912-1A
Other languages
English (en)
Inventor
Glynn Thomas Faircloth
Bastian Nuyen
Steve Weitman
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of BR0114912A publication Critical patent/BR0114912A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Patente de Inveção: "KAHALALIDE F". A Invenção refere-se a novas formulações e usos do kahalalide F.
BR0114912-1A 2000-10-31 2001-10-31 Kahalalide f BR0114912A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24447100P 2000-10-31 2000-10-31
US24622900P 2000-11-06 2000-11-06
US34844901P 2001-10-19 2001-10-19
PCT/GB2001/004821 WO2002036145A2 (en) 2000-10-31 2001-10-31 Kahalalide f formulation

Publications (1)

Publication Number Publication Date
BR0114912A true BR0114912A (pt) 2003-10-14

Family

ID=27399760

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114912-1A BR0114912A (pt) 2000-10-31 2001-10-31 Kahalalide f

Country Status (22)

Country Link
US (1) US7473681B2 (pt)
EP (1) EP1330258B1 (pt)
JP (2) JP2004512370A (pt)
KR (1) KR100834138B1 (pt)
CN (1) CN1568192A (pt)
AT (1) ATE314084T1 (pt)
AU (2) AU1074902A (pt)
BR (1) BR0114912A (pt)
CA (1) CA2425627A1 (pt)
CY (1) CY1105009T1 (pt)
CZ (1) CZ20031211A3 (pt)
DE (1) DE60116359T2 (pt)
DK (1) DK1330258T3 (pt)
ES (1) ES2256305T3 (pt)
HK (1) HK1054192B (pt)
HU (1) HUP0600031A3 (pt)
IL (2) IL155297A0 (pt)
MX (1) MXPA03003704A (pt)
NO (1) NO331082B1 (pt)
NZ (1) NZ525243A (pt)
SK (1) SK286421B6 (pt)
WO (1) WO2002036145A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
US20050054555A1 (en) * 2001-10-19 2005-03-10 Jose Jimeno Kahalalide compounds for use in cancer therapy
WO2003033012A1 (en) * 2001-10-19 2003-04-24 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
SI1572726T1 (sl) * 2002-10-18 2011-04-29 Pharma Mar Sau 4-metilheksanoiäśna kahalalid f spojina
MXPA05004133A (es) * 2002-10-18 2005-10-05 Pharma Mar Sau Nuevos compuestos antitumorales.
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
DE10329847A1 (de) * 2003-07-02 2005-01-20 Toximed Gmbh Pharmazeutischer Wirkstoff gegen Prostatakarzinome
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
GB0408958D0 (en) * 2004-04-22 2004-05-26 Pharma Mar Sa Convergent synthesis for kahalalide compounds
KR101287918B1 (ko) * 2004-10-26 2013-07-19 오르토 바이오테크 프로덕츠 엘.피. 엑티나시딘 ７４３과 조합된 페길화된 리포좀 독소루비신
SI1658848T1 (sl) * 2004-10-29 2007-12-31 Pharma Mar Sa Formulacije vsebujoäśe ekteinascidin in disaharid
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CA2703720A1 (en) * 2007-10-19 2009-04-23 Albert Einstein College Of Medicine Of Yeshiva University Improved antitumoral treatments
CA2713459A1 (en) * 2008-01-30 2009-08-06 Pharma Mar, S.A. Improved antitumoral treatments
AU2009221120A1 (en) * 2008-03-07 2009-09-11 Pharma Mar, S.A. Improved antitumoral treatments
WO2009135939A2 (en) * 2008-05-09 2009-11-12 Pharma Mar, S.A. Depsipeptide for use in cancer therapy
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
JP2799483B2 (ja) 1988-03-09 1998-09-17 大塚製薬株式会社 インターロイキン−１β組成物の安定化方法
GB8819607D0 (en) * 1988-08-17 1988-09-21 Wellcome Found Novel combination
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
JP2971680B2 (ja) 1991-10-02 1999-11-08 山之内製薬株式会社 組織プラスミノーゲン活性化因子含有組成物
JPH0597703A (ja) 1991-10-04 1993-04-20 Yamanouchi Pharmaceut Co Ltd 改変型組織プラスミノーゲン活性化因子含有組成物
US5550124A (en) 1991-12-10 1996-08-27 University Of Southern California Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
GB9302046D0 (en) * 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
JP3927248B2 (ja) * 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
JPH1014581A (ja) 1996-07-08 1998-01-20 Morinaga Milk Ind Co Ltd ウサギ型マクロファージ・コロニー刺激因子及びこれをコードするｄｎａ断片
JP4025394B2 (ja) * 1996-09-06 2007-12-19 財団法人化学及血清療法研究所 組織プラスミノーゲン活性化因子医薬組成物
DK0827751T3 (da) 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
GB9807639D0 (en) 1998-04-14 1998-06-10 Kennedy Rheumatology Inst Anti-inflammatory agents
CN1322136A (zh) 1998-09-23 2001-11-14 马库斯·基普 用于选择性神经元辐射防护的神经亲免素类物质
GB0002952D0 (en) 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
US20050054555A1 (en) 2001-10-19 2005-03-10 Jose Jimeno Kahalalide compounds for use in cancer therapy

Also Published As

Publication number Publication date
US20040067895A1 (en) 2004-04-08
KR100834138B1 (ko) 2008-06-02
JP2010047601A (ja) 2010-03-04
NZ525243A (en) 2005-01-28
DE60116359T2 (de) 2006-09-28
EP1330258A2 (en) 2003-07-30
PL360848A1 (en) 2004-09-20
WO2002036145A3 (en) 2002-10-17
HUP0600031A3 (en) 2012-02-28
HK1054192A1 (en) 2003-11-21
CA2425627A1 (en) 2002-05-10
HUP0600031A2 (en) 2006-05-29
SK286421B6 (sk) 2008-09-05
KR20030044005A (ko) 2003-06-02
JP2004512370A (ja) 2004-04-22
AU1074902A (en) 2002-05-15
WO2002036145A2 (en) 2002-05-10
SK5022003A3 (en) 2003-12-02
ES2256305T3 (es) 2006-07-16
AU2002210749B2 (en) 2006-12-21
IL155297A0 (en) 2003-11-23
MXPA03003704A (es) 2004-05-04
NO331082B1 (no) 2011-10-03
ATE314084T1 (de) 2006-01-15
HK1054192B (zh) 2006-09-08
DE60116359D1 (de) 2006-02-02
US7473681B2 (en) 2009-01-06
NO20031860D0 (no) 2003-04-25
CZ20031211A3 (cs) 2003-09-17
WO2002036145A8 (en) 2003-10-23
NO20031860L (no) 2003-06-30
DK1330258T3 (da) 2006-05-22
EP1330258B1 (en) 2005-12-28
CY1105009T1 (el) 2010-03-03
CN1568192A (zh) 2005-01-19
IL155297A (en) 2010-05-31

Similar Documents

Publication Publication Date Title
BR0114912A (pt) Kahalalide f
ATE411332T1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
MY136707A (en) Thrombopoietin mimetics
BR0109272A (pt) Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos
TR200401871T4 (tr) Değiştirilen oktanoil amitlerin (octanoyl amides) hazırlanması
MXPA02012937A (es) Combinaciones de productos activos con propiedades insecticidas y acaricidas.
BR0114059A (pt) Derivados de resorcinol
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
BR0109541A (pt) Combinações de subst ncias ativas com propriedades inseticidas e acaricidas
ATE330017T1 (de) Kallikrein gen
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
FR2805461B1 (fr) Nouveaux agents de gommage cutane et nouvelles compositions cosmetiques
PA8449301A1 (es) Composiciones farmaceuticas
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
BR0114065A (pt) Triazolo-epotilonas
WO2002077233A8 (en) 38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
BR0209455A (pt) Dentifrìcio
DE60143020D1 (de) 9-alkylamino-1-nitroacridin-derivate
Holsinger Voice of the Living Light: Hildegard of Bingen and Her World
IT1308656B1 (it) Strumentario per l'applicazione di chiodi endomidollari per fratturemetadiafisiarie e diafisiarie del femore e della tibia.
AU139892S (en) A Paving Block

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time